Windtree Therapeutics IncWindtree Therapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This dashboard includes a Q&A section on Windtree Therapeutics Inc. This analysis of Windtree Therapeutics Inc leverages data from across the web as well as from public documents by Windtree Therapeutics Inc. This assessment of Windtree Therapeutics Inc was prepared by All Street Sevva using cutting edge artificial intelligence.

Windtree Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.4; made up of an environmental score of 0.0, social score of 3.2 and governance score of 4.0.

SDG Transparency Score for Windtree Therapeutics Inc 

2.4

Low Impact
0 - 3
Medium
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Windtree Therapeutics Inc 
0.0

Environmental

3.2

Social

4.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
.........
1499Verici Dx Plc
2.5
Medium
1499Verve Therapeutics Inc
2.5
Medium
1512Windtree Therapeutics Inc
2.4
Medium
1512CEL-SCI Corp
2.4
Medium
1512Allena Pharmaceuticals Inc
2.4
Medium
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Windtree Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc offer flexible work?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Windtree Therapeutics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose water use targets?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Windtree Therapeutics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Windtree Therapeutics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Windtree Therapeutics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose its waste policy?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does Windtree Therapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Windtree Therapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Windtree Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart failure, as well as in Phase IIa clinical trial for the treatment of early cardiogenic shock; AEROSURF, an aerosolized KL4 surfactant, which is in Phase IIb clinical trial to treat respiratory distress syndrome in premature infants; Lyophilized KL4 surfactant, which is in Phase IIa clinical trial for the treatment of lung injury resulting from COVID-19; and Rostafuroxin that is in Phase IIb clinical trial for the treatment of genetically associated hypertension. It has a collaboration with Universita degli Studi di Milano-Bicocca for the discovery and development of new SERCA2a compounds for the treatment of chronic and acute human heart failure; a strategic alliance with Laboratorios del Dr. Esteve, S.A. for the development, marketing, and sales of a portfolio of potential KL4 surfactant products; and collaboration with Battelle Memorial Institute for development of its ADS for use in its phase III program. The company was formerly known as Discovery Laboratories, Inc. and changed its name to Windtree Therapeutics, Inc. in April 2016. Windtree Therapeutics, Inc. was incorporated in 1992 and is headquartered in Warrington, Pennsylvania. Windtree Therapeutics, Inc. is a subsidiary of Lee's Pharmaceutical Holdings Limited.

Sorry!

Failed to process!